These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. Espinel-Ingroff A. J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049 [Abstract] [Full Text] [Related]
5. In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi. Marco F, Pfaller MA, Messer SA, Jones RN. Mycopathologia; 1998 Oct; 141(2):73-7. PubMed ID: 9750338 [Abstract] [Full Text] [Related]
6. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Pfaller MA, Messer SA, Hollis RJ, Jones RN, SENTRY Participants Group. Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586 [Abstract] [Full Text] [Related]
7. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. Gehrt A, Peter J, Pizzo PA, Walsh TJ. J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745 [Abstract] [Full Text] [Related]
9. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M. Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312 [Abstract] [Full Text] [Related]
11. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Pfaller MA, Messer SA, Coffman S. Antimicrob Agents Chemother; 1997 Apr; 41(4):763-6. PubMed ID: 9087485 [Abstract] [Full Text] [Related]
13. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. Cuenca-Estrella M, Mellado E, Díaz-Guerra TM, Monzón A, Rodríguez-Tudela JL. J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178 [Abstract] [Full Text] [Related]
15. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988 [Abstract] [Full Text] [Related]
17. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Martos AI, Romero A, González MT, González A, Serrano C, Castro C, Pemán J, Cantón E, Martín-Mazuelos E. Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131 [Abstract] [Full Text] [Related]